Pediatric

I'm Aware That I'm Rare: Dunbar Ivy, MD

I'm Aware That I'm Rare: Dunbar Ivy, MD

Dunbar Ivy, MD is currently the Section Head of Pediatric Cardiology and the Director of the Pediatric Pulmonary Hypertension Program at the University of Colorado. He has published over 100 medical articles, primarily focusing on pulmonary hypertension in children. He discusses the importance of Pediatric Pulmonary Hypertension Guidelines, the work of the Pediatric Pulmonary Hypertension Network (PPHNet.org) and how a PH Research app could change patient care.

I'm Aware That I'm Rare: Jeffrey Fineman, MD

I'm Aware That I'm Rare: Jeffrey Fineman, MD

Dr. Jeffrey Fineman is a pediatric critical care specialist, or intensivist, and the division chief of Critical Care at UCSF Benioff Children’s Hospital, San Francisco. He also is an investigator of the Cardiovascular Research Institute. His research has led to new therapies for pulmonary hypertension, including a drug called inhaled nitric oxide, which was approved by the U.S. Food and Drug Administration. Fineman's research has focused on diseases related to pulmonary circulation. In particular, he has been interested in the pathophysiology of pulmonary hypertension and heads a laboratory, funded by the National Institutes of Health, for these investigations.

I'm Aware That I'm Rare: Jackie Szmuszkovicz, MD

I'm Aware That I'm Rare: Jackie Szmuszkovicz, MD

Dr. Szmuszkovicz works in Los Angeles, CA and specializes in Pediatric Cardiology. She provides comprehensive care to patients with cardiovascular problems. Dr. Szmuszkovicz is affiliated with Children’s Hospital Los Angeles, Hollywood Presbyterian Medical Center and LAC USC Medical Center.

I'm Aware That I'm Rare: UCSF's CPVD 10th Int'l Conference

I'm Aware That I'm Rare: UCSF's CPVD 10th Int'l Conference

Over the past decade, great strides have been made in the understanding of the pathobiology of pulmonary vascular disease, and from these findings new therapeutic options have emerged. It is increasingly clear that pulmonary vascular pathology is integral to a number of childhood disorders. 

At the 10th International Conference Neonatal & Childhood Pulmonary Vascular Disease, chair's Jeffrey R. Fineman, MD and Ian Adatia, MBChB, FRCP will bring together international experts to explore their current understanding of the basic pathobiology as well as new and future therapies for neonatal, pediatric, and adult pulmonary vascular diseases. Learn more here.

I'm Aware That I'm Rare: Betty Lou Wojciechowski

I'm Aware That I'm Rare: Betty Lou Wojciechowski

Betty Lou “Wojo” is a retired school teacher who lost her husband Jerry and two children (Michael and Matthew) to Pulmonary Arterial Hypertension (PAH), a rare blood vessel disorder that affects people of all ages and causes high blood pressure in the arteries of the lungs that can lead to heart failure. Betty Lou discusses how she turned her sorrow into strength and why the Wojo family has established PH research grants in Jerry, Michael and Matthew’s names.

I'm Aware That I'm Rare: Ian Adatia, MD

I'm Aware That I'm Rare: Ian Adatia, MD

Dr. Ian Adatia has spent the last 25 years helping to improve care for babies, children and young people with pulmonary vascular disease. He is a clinician scholar and researcher. He has developed innovative therapies for children with pulmonary hypertension, and the first childhood pulmonary hypertension clinic in North America.

 
 
 
 

Engage for a cure. Like & follow @phaware across social media. 
Download our phaware®, phaware podcast® &  phaware365®  apps
available on the App Store®  and on Google Play® . 

Use the #phaware hashtag and post inspirational stories on your own social media sites.
Invite others to heighten global pulmonary hypertension awareness and help make PH history.